Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 34,944 shares at $24.15 ($845K) on 2025-01-07, disclosed to the SEC on 2025-01-10.
Scheduled sale ($845k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.15 | 20,260 | $489K | 57.9% |
| 2 | $24.17 | 6,577 | $159K | 18.8% |
| 3 | $24.17 | 6,577 | $159K | 18.8% |
| 4 | $24.56 | 1,440 | $35K | 4.2% |
| 5 | $24.60 | 90 | $2K | 0.3% |
| Total | $24.18 avg | 34,944 |
| $845K |
| 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |